FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3111115250> ?p ?o ?g. }

• W3111115250 endingPage "19" @default.
• W3111115250 startingPage "12" @default.
• W3111115250 abstract "Background and Purpose: We determined to identify patients with unknown onset stroke who could have favorable 90-day outcomes after low-dose thrombolysis from the THAWS (Thrombolysis for Acute Wake-Up and Unclear-Onset Strokes With Alteplase at 0.6 mg/kg) database. Methods: This was a subanalysis of an investigator-initiated, multicenter, randomized, open-label, blinded–end point trial. Patients with stroke with a time last-known-well >4.5 hours who showed a mismatch between diffusion-weighted imaging (DWI) and fluid-attenuated inversion recovery were randomly assigned (1:1) to receive alteplase at 0.6 mg/kg intravenously or standard medical treatment. The patients were dichotomized by ischemic core size or National Institutes of Health Stroke Scale score, and the effects of assigned treatments were compared in each group. The efficacy outcome was favorable outcome at 90 days, defined as a modified Rankin Scale score of 0 to 1. Results: The median DWI-Alberta Stroke Program Early CT Score (ASPECTS) was 9, and the median ischemic core volume was 2.5 mL. Both favorable outcome (47.1% versus 48.3%) and any intracranial hemorrhage (26% versus 14%) at 22 to 36 hours were comparable between the 68 thrombolyzed patients and the 58 control patients. There was a significant treatment-by-cohort interaction for favorable outcome between dichotomized patients by ASPECTS on DWI ( P =0.026) and core volume ( P =0.035). Favorable outcome was more common in the alteplase group than in the control group in patients with DWI-ASPECTS 5 to 8 (RR, 4.75 [95% CI, 1.33–30.2]), although not in patients with DWI-ASPECTS 9 to 10. Favorable outcome tended to be more common in the alteplase group than in the control group in patients with core volume >6.4 mL (RR, 6.15 [95% CI, 0.87–43.64]), although not in patients with volume ≤6.4 mL. The frequency of any intracranial hemorrhage did not differ significantly between the 2 treatment groups in any dichotomized patients. Conclusions: Patients developing unknown onset stroke with DWI-ASPECTS 5 to 8 showed favorable outcomes more commonly after low-dose thrombolysis than after standard treatment. Registration: URL: https://www.clinicaltrials.gov ; Unique Identifier: NCT02002325. URL: https://www.umin.ac.jp/ctr ; Unique Identifier: UMIN000011630." @default.
• W3111115250 created "2020-12-21" @default.
• W3111115250 creator A5003552934 @default.
• W3111115250 creator A5003891237 @default.
• W3111115250 creator A5006679430 @default.
• W3111115250 creator A5007150218 @default.
• W3111115250 creator A5008694263 @default.
• W3111115250 creator A5009946794 @default.
• W3111115250 creator A5010390591 @default.
• W3111115250 creator A5011795540 @default.
• W3111115250 creator A5011996744 @default.
• W3111115250 creator A5012858671 @default.
• W3111115250 creator A5013790464 @default.
• W3111115250 creator A5015763821 @default.
• W3111115250 creator A5017561714 @default.
• W3111115250 creator A5017765343 @default.
• W3111115250 creator A5018515174 @default.
• W3111115250 creator A5019613748 @default.
• W3111115250 creator A5019632697 @default.
• W3111115250 creator A5019738100 @default.
• W3111115250 creator A5022418335 @default.
• W3111115250 creator A5024978280 @default.
• W3111115250 creator A5026956856 @default.
• W3111115250 creator A5027543726 @default.
• W3111115250 creator A5028025164 @default.
• W3111115250 creator A5029365658 @default.
• W3111115250 creator A5029421463 @default.
• W3111115250 creator A5029640488 @default.
• W3111115250 creator A5032119070 @default.
• W3111115250 creator A5033294815 @default.
• W3111115250 creator A5033737144 @default.
• W3111115250 creator A5035202189 @default.
• W3111115250 creator A5035360381 @default.
• W3111115250 creator A5035717519 @default.
• W3111115250 creator A5035732835 @default.
• W3111115250 creator A5036467430 @default.
• W3111115250 creator A5040511706 @default.
• W3111115250 creator A5040997718 @default.
• W3111115250 creator A5041604185 @default.
• W3111115250 creator A5042534277 @default.
• W3111115250 creator A5043643761 @default.
• W3111115250 creator A5044771918 @default.
• W3111115250 creator A5045027100 @default.
• W3111115250 creator A5046078673 @default.
• W3111115250 creator A5047400478 @default.
• W3111115250 creator A5049935624 @default.
• W3111115250 creator A5051426211 @default.
• W3111115250 creator A5051502454 @default.
• W3111115250 creator A5052029560 @default.
• W3111115250 creator A5053022874 @default.
• W3111115250 creator A5053048284 @default.
• W3111115250 creator A5053317374 @default.
• W3111115250 creator A5056591092 @default.
• W3111115250 creator A5058334370 @default.
• W3111115250 creator A5058762503 @default.
• W3111115250 creator A5059500796 @default.
• W3111115250 creator A5060565773 @default.
• W3111115250 creator A5060768433 @default.
• W3111115250 creator A5061755175 @default.
• W3111115250 creator A5064012927 @default.
• W3111115250 creator A5064704555 @default.
• W3111115250 creator A5064878753 @default.
• W3111115250 creator A5067066104 @default.
• W3111115250 creator A5067341497 @default.
• W3111115250 creator A5067735532 @default.
• W3111115250 creator A5067843277 @default.
• W3111115250 creator A5068682805 @default.
• W3111115250 creator A5069024409 @default.
• W3111115250 creator A5070611644 @default.
• W3111115250 creator A5070691071 @default.
• W3111115250 creator A5071452719 @default.
• W3111115250 creator A5073245835 @default.
• W3111115250 creator A5074288552 @default.
• W3111115250 creator A5075739501 @default.
• W3111115250 creator A5077566922 @default.
• W3111115250 creator A5079833990 @default.
• W3111115250 creator A5080104670 @default.
• W3111115250 creator A5080804477 @default.
• W3111115250 creator A5081143725 @default.
• W3111115250 creator A5081250273 @default.
• W3111115250 creator A5085916157 @default.
• W3111115250 creator A5087083278 @default.
• W3111115250 creator A5088982453 @default.
• W3111115250 creator A5089174689 @default.
• W3111115250 creator A5091161390 @default.
• W3111115250 date "2021-01-01" @default.
• W3111115250 modified "2023-09-30" @default.
• W3111115250 title "Magnetic Resonance Imaging–Guided Thrombolysis (0.6 mg/kg) Was Beneficial for Unknown Onset Stroke Above a Certain Core Size" @default.
• W3111115250 cites W1558629994 @default.
• W3111115250 cites W1973913902 @default.
• W3111115250 cites W1983400608 @default.
• W3111115250 cites W2048007349 @default.
• W3111115250 cites W2081615170 @default.
• W3111115250 cites W2093409635 @default.
• W3111115250 cites W2104657667 @default.
• W3111115250 cites W2110483627 @default.
• W3111115250 cites W2113514989 @default.
• W3111115250 cites W2122396373 @default.

• next